News | November 27, 2007

Updated Registry Aids Vascular Surgeons

November 28, 2007 - Recent statistical updates are published in the December 2007 issue of the Journal of Vascular Surgery that compare carotid endarterectomy (CEA), lower extremity bypass (LEB) and infrarenal abdominal aortic aneurysm (AAA) (both open and endovascular repairs).
Between 2003 and December 2006, forty-eight vascular surgeons from nine hospitals that comprise the Vascular Study Group of Northern New England recorded prospective data from 6,143 patient procedures (83 percent had follow-up data at one year), risk factors and in-hospital outcomes.
"The latest data shows stroke and death following CEA was 1.0 percent; major amputation or death following LEB was 3.8 percent; and death following AAA repair was 2.9 percent for open surgery and 0.4 percent for endovascular repair," said Jack L. Cronenwett, M.D., department of Vascular Surgery section chief at Dartmouth-Hitchcock Medical Center in Lebanon, N.H.
"The Vascular Study Group of Northern New England registry data allows surgeons to discuss techniques or management that could affect outcomes in the future," said Dr. Cronenwett. "Our efforts focus on analyzing risk-adjusted outcomes to better understand the centers' variation and improve patient selection, while striving to continuously improve quality, safety, effectiveness and cost of care. This registry is a model that could be adopted by other regions for improving patient outcomes and enabling pay-for-performance reporting."
Dr. Cronenwett added that one of the most important accomplishments of the registry has been the success of process improvement efforts. "For example, our new data shows we have significantly increased pre-operative beta-blockers from 72 percent to 91 percent; antiplatelet agents from 73 percent to 83 percent and statins from 54 percent to 72 percent," he said.
Results are analyzed at a central site and then reported anonymously to each center at bi-annual meetings. Mortality and compliance with procedure entry are validated by independent comparison with hospital administrative data through a centralized audit. This data also are used to audit compliance with procedure entry in order to ensure accuracy. Reports include key process and outcome variables, so that each center and surgeon can assess their results in comparison to the entire group over time.
For more information: www.jvascsurg.org

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init